Bacitracin vs Teixobactin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Bacitracin is a polycyclic peptide antibiotic from Bacillus subtilis licheniformis, first isolated in 1945 from wound cultures of a 7-year-old girl named Margaret Tracy (hence "bacitracin"). It is available OTC in Neosporin and similar triple-antibiotic ointments and is one of th...
Calculate Bacitracin dose →Teixobactin was reported in Nature in 2015 as the first new antibiotic class discovered in 30 years, isolated from uncultured soil bacteria Eleftheria terrae using the iChip (isolation chip) technology that allows cultivation of previously unculturable organisms. Teixobactin bind...
Calculate Teixobactin dose →| Parameter | Bacitracin | Teixobactin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | FDA Approved (topical) | Preclinical |
| Half-Life | Hours (topical) | Hours (in vivo) |
| Typical Dose | 400-500 units/g ointment | N/A |
| Frequency | 1-3x daily | N/A |
| Route | Topical | Research only (IV in animal studies) |
| FDA Status | Approved (topical) | Not approved (preclinical) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.